Skip to main content
RACS ASC 2024

How to navigate Primary Cutaneous CD4+ T-Cell Lymphoproliferative Disorder

Poster

Presentation Description

Institution: Alfred Health - Victoria, Australia

Purpose: Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder is a rare and diagnostically challenging condition. This case report aims to increase awareness of this diagnosis and provide insights into optimal management. Method: A 47-year-old female presented with a forehead skin nodule that progressed into a 2.5cm lesion over several weeks, after a suspected insect bite. Histopathology from an excisional biopsy suggested marginal-zone lymphoma. Subsequently, the biopsy was reviewed by two pathologists at quaternary cancer centres, leading to the identification of CD4+ small/medium pleomorphic lymphoproliferative disorder before referring to haematologists. The distinction between this disorder and primary cutaneous lymphoma is crucial - significantly influencing prognosis and management. Primary Cutaneous CD4+ small/medium T-cell lymphoproliferative disorder is benign. Its indolent course discourages use of aggressive systemic treatments. Management includes excision, radiotherapy, or surveillance. This patient opted for close observation with the option of low-dose radiotherapy in case of recurrence. In contrast, cutaneous marginal-zone B-cell lymphoma, albeit low-grade, is malignant. Management includes staging, wide excision, radiotherapy, or systemic treatments for multifocal disease. Results/Conclusion: This case demonstrates the diagnostic challenges associated with distinguishing cutaneous CD4+ small/medium T-cell lymphoproliferative from other skin lesions with similar clinical features. Careful histological analysis and a multidisciplinary approach involving surgeons, pathologists, and haematologists is required for accurate diagnosis and management.

Speakers

Authors

Authors

Dr Nupur Shukla - , Dr Lipi Shukla -